Stryker Corp
SYK- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000310764
In the last 90 days, Stryker Corp insiders filed 1 open-market purchase and 3 sales; 2,268 institutions reported holding it in 13F filings for Q2 2026, worth $97.2B in total; Fundsmith is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Stryker Corp as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1,584
- −67 vs. Q1 2022
- Shares held
- 291.2M
- +4.51M (+1.6%) vs. Q1 2022
- Total value
- $57.9B
- −$18.7B (−24.4%) vs. Q1 2022
- New holders
- 114
- 607 more added
- Sold out
- 181
- 580 more reduced
25 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SYK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2,268 | $97.2B |
| Q1 2026 | 2,313 | $98.4B |
| Q4 2025 | 2,331 | $106.9B |
| Q3 2025 | 2,274 | $109.9B |
| Q2 2025 | 2,258 | $120.0B |
| Q1 2025 | 2,235 | $113.0B |
| Q4 2024 | 2,201 | $107.7B |
| Q3 2024 | 2,040 | $107.9B |
| Q2 2024 | 1,991 | $100.3B |
| Q1 2024 | 1,993 | $104.8B |
| Q4 2023 | 1,886 | $88.0B |
| Q3 2023 | 1,775 | $80.3B |
| Q2 2023 | 1,788 | $89.6B |
| Q1 2023 | 1,707 | $85.2B |
| Q4 2022 | 1,653 | $73.5B |
| Q3 2022 | 1,534 | $60.1B |
| Q2 2022 | 1,584 | $57.9B |
| Q1 2022 | 1,676 | $77.2B |
| Q4 2021 | 1,658 | $75.6B |
| Q3 2021 | 1,562 | $74.1B |
| Q2 2021 | 1,558 | $72.1B |
| Q1 2021 | 1,528 | $67.5B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Stryker Corp; share changes are against Q1 2022.